Skip to main content

biotech-blood-pixa

Has venture capital always been a bad model for the life sciences?

Andrew Lo, director of the MIT Laboratory for Financial Engineering, dismissed the sector outright on stage Sunday at the Cleveland Clinic Medical Innovation Summit. His rationale:

{iframe}http://medcitynews.com/2015/10/is-venture-capital-bad-for-life-sciences-3-reasons-why-and-what-should-replace-it/?utm_source=MedCity+News+Subscribers&utm_campaign=f6365420d6-MCN+Daily+Email&utm_medium=email&utm_term=0_5092836c41-f6365420d6-408826397{/iframe}

Search

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.